respiratori
viral
infect
often
implic
trigger
chronic
rhinosinus
cr
flareup
howev
pauciti
respiratori
viral
surveil
studi
cr
patient
studi
could
elucid
potenti
role
virus
promot
symptom
aggrav
mucos
inflamm
therefor
prospect
casecontrol
studi
conduct
determin
preval
respiratori
virus
cr
patient
noncr
control
nasal
lavag
fluid
turbin
epitheli
cell
collect
prospect
cr
patient
control
multiplex
pcr
use
identifi
common
respiratori
virus
sampl
type
infect
rate
compar
group
respiratori
virus
detect
lavag
sampl
scrape
sampl
cr
patient
overal
infect
rate
significantli
differ
cr
patient
control
odd
ratio
lavag
scrape
sampl
multipl
viral
infect
detect
frequent
lavag
sampl
cr
patient
control
p
odd
ratio
rhinoviru
preval
viru
viru
significantli
differ
infect
rate
cr
patient
control
sampl
odd
ratio
lavag
scrape
sampl
studi
detect
higher
preval
respiratori
virus
cr
patient
control
suggest
may
signific
associ
inflamm
cr
respiratori
virus
particularli
rhinoviru
studi
investig
exact
role
highli
preval
respiratori
virus
cr
patient
symptomat
aggrav
ongo
mucos
inflamm
c
hronic
rhinosinus
cr
one
preval
chronic
ill
etiolog
pathogenesi
cr
well
understood
clinic
respiratori
viral
infect
often
implic
trigger
cr
flareup
nevertheless
mani
research
consid
insuffici
evid
respiratori
viral
infect
relat
pathogenesi
cr
virus
virtual
ubiquit
gener
popul
link
persist
sinonas
inflamm
howev
experiment
studi
suggest
import
role
viral
pathogen
exacerb
ongo
inflamm
cr
vitro
studi
use
human
sinonas
epitheli
cell
demonstr
viral
infect
exposur
synthet
viral
analogu
increas
express
immun
effector
respiratori
viral
infect
also
known
damag
nasal
epitheli
cell
cilia
caus
dysfunct
intercellular
junction
tight
junction
adheren
junction
increas
bacteri
adhes
asthma
cr
common
airway
diseas
link
atopi
allerg
inflamm
potenti
parallel
establish
pathogenesi
condit
number
studi
asthmat
patient
demonstr
strong
associ
respiratori
viral
infect
acut
exacerb
asthma
pilot
studi
test
presenc
rhinoviru
nasal
caviti
cr
patient
rhinovirus
detect
epitheli
cell
sampl
cr
patient
wherea
none
detect
control
preliminari
studi
suggest
rhinoviru
may
associ
cr
pathogenesi
although
number
viral
speci
test
number
patient
enrol
limit
also
pauciti
respiratori
viral
surveil
studi
cr
patient
studi
could
elucid
associ
mucos
inflamm
cr
respiratori
virus
thu
preval
viral
pathogen
cr
patient
sign
acut
viral
infect
investig
prospect
studi
use
multiplex
pcr
assay
sensit
detect
variou
respiratori
virus
nasal
sampl
sampl
collect
control
subject
without
cr
respiratori
viru
infect
rate
cr
patient
compar
control
subject
data
might
provid
new
insight
put
role
respiratori
virus
promot
symptom
aggrav
mucos
inflamm
cr
studi
popul
one
hundr
twentytwo
patient
recruit
prospect
receiv
endoscop
sinu
surgeri
cr
control
optim
medic
treatment
august
march
asan
medic
center
seoul
south
korea
patient
met
establish
diagnost
criteria
cr
patient
fungal
sinus
current
immunotherapi
aspirin
desensit
cystic
fibrosi
exclud
studi
reason
exclus
treatment
local
oral
steroid
within
previou
week
control
volunt
requir
plan
surgeri
chronic
tonsil
thyroid
mass
none
control
experienc
cr
presenc
sinus
control
group
rule
base
histori
physic
examin
plain
sinu
xray
andor
comput
tomographi
ct
imag
patient
control
subject
check
viral
upper
respiratori
infect
uri
period
uri
symptom
assess
use
jackson
scale
eight
symptom
nasal
discharg
nasal
congest
sneez
cough
malais
throat
discomfort
feverchil
headach
eleven
cr
patient
symptom
sign
viral
uri
preced
week
exclud
studi
asthma
defin
histori
asthma
symptom
recurr
dyspnea
wheez
cough
chest
tight
associ
revers
airflow
obstruct
measur
spirometri
allerg
rhiniti
defin
allerg
symptom
wateri
rhinorrhea
nasal
obstruct
nasal
itch
sneez
h
day
posit
skin
prick
test
detect
serumspecif
ige
studi
approv
institut
review
board
asan
medic
center
seoul
south
korea
adult
particip
legal
author
repres
children
provid
inform
consent
collect
sampl
nasal
sampl
collect
particip
summer
spring
august
march
month
sampl
size
approxim
equal
distribut
month
ie
samplesmonth
cr
patient
samplesmonth
control
subject
verifi
presenc
respiratori
virus
studi
popul
two
highsensit
sampl
techniqu
use
ie
nasal
lavag
scrape
nasal
epithelium
inferior
turbin
method
describ
previou
studi
mucos
scrape
found
sensit
nasal
lavag
viral
detect
oper
room
nasal
lavag
sampl
collect
immedi
induct
gener
anesthesia
balloon
cathet
place
posterior
nasal
caviti
choana
steril
salin
solut
nacl
room
temperatur
aerosol
nostril
use
needlefre
syring
procedur
repeat
altern
nostril
ml
lavag
fluid
recov
lavag
inferior
turbin
epitheli
cell
scrape
medial
aspect
middl
third
inferior
turbin
use
steril
dispos
rhinoprob
mucos
curett
arlington
scientif
inc
springvil
ut
scrape
sampl
remov
immedi
rhinoprob
cusp
transfer
plastic
tube
contain
ml
steril
phosphatebuff
salin
sampl
frozen
immedi
collect
store
use
identif
respiratori
virus
viral
rna
extract
l
respiratori
sampl
use
qiaamp
viral
rna
kit
qiagen
gmbh
hilden
germani
accord
manufactur
instruct
synthes
cdna
revers
transcript
perform
use
revertaid
firststrand
cdna
synthesi
kit
fermenta
burlington
canada
final
volum
l
contain
random
hexam
primer
mm
concentr
deoxynucleosid
triphosph
dntp
u
ribolock
rnase
inhibitor
reaction
buffer
u
revertaid
moloney
murin
leukemia
viru
mmlv
revers
transcriptas
cdna
subject
multiplex
pcr
use
seeplex
ace
detect
kit
seeplex
seegen
inc
seoul
south
korea
accord
manufactur
instruct
briefli
l
synthes
firststrand
cdna
primer
mix
multiplex
master
mix
taq
dna
polymeras
dntp
includ
l
solut
mix
primer
mix
contain
intern
control
templat
primer
pair
valid
pcr
three
reaction
use
primer
mix
b
c
conduct
sampl
accord
kit
instruct
specif
primer
target
respiratori
viru
shown
tabl
multiplex
pcr
detect
rhinovirus
enterovirus
parainfluenza
virus
influenza
virus
b
respiratori
syncyti
virus
rsv
b
coronavirus
adenoviru
human
metapneumoviru
hmpv
human
bocavirus
pcr
use
follow
condit
initi
denatur
min
cycl
min
min
final
extens
min
multiplex
pcr
product
visual
electrophoresi
agaros
gel
statist
analysi
pearson
chisquar
test
fisher
exact
test
twotail
use
compar
viru
detect
rate
cr
patient
control
subject
odd
ratio
confid
interv
ci
also
calcul
statist
analys
perform
use
spss
version
spss
inc
chicago
il
p
valu
regard
signific
august
march
studi
enrol
patient
cr
control
subject
demograph
clinic
data
shown
tabl
among
cr
patient
asthma
present
patient
allerg
rhiniti
present
patient
comparison
case
patient
control
subject
show
two
group
differ
significantli
term
age
gender
concomit
asthma
allerg
rhiniti
p
studi
includ
cr
patient
nasal
polyp
cr
patient
without
nasal
polyp
associ
asthma
allerg
rhiniti
nasal
polyp
respiratori
viru
detect
rate
multipl
viru
detect
cr
patient
respect
p
addit
statist
signific
differ
relat
age
patient
virus
detect
whether
multipl
virus
detect
rate
detect
p
viral
detect
nasal
lavag
sampl
pcr
analysi
posit
one
respiratori
virus
nasal
lavag
sampl
cr
patient
control
subject
signific
differ
overal
viru
detect
rate
two
group
p
tabl
cr
patient
like
infect
virus
control
subject
without
cr
base
analysi
nasal
lavag
fluid
ci
interestingli
coinfect
viru
detect
cr
patient
two
control
subject
coinfect
rate
significantli
differ
lavag
sampl
two
group
p
ci
nineteen
cr
patient
infect
ii
viral
detect
mucos
scrape
sampl
mucos
scrape
sampl
pcr
analysi
posit
one
respiratori
virus
cr
patient
control
subject
signific
differ
overal
viru
detect
rate
two
group
p
tabl
cr
patient
like
infect
virus
control
subject
accord
mucos
scrape
sampl
ci
multipl
viral
infect
identifi
cr
patient
five
control
subject
fourteen
cr
patient
infect
two
speci
viru
patient
infect
three
speci
viru
patient
infect
four
speci
viru
contrast
nasal
lavag
fluid
analysi
signific
differ
coinfect
rate
two
group
p
result
pcr
test
viru
shown
tabl
pcr
analysi
rhinoviru
posit
cr
group
control
group
rhinoviru
respiratori
viru
significantli
differ
detect
rate
cr
patient
control
subject
p
ci
cr
group
posit
parainfluenza
influenza
rsv
coronaviru
adenoviru
enteroviru
hmpv
none
human
bocaviru
signific
differ
posit
detect
rate
parainfluenza
influenza
rsv
coronaviru
adenoviru
hmpv
human
bocaviru
cr
control
group
p
result
consid
posit
either
lavag
scrap
c
detect
rate
cr
patient
significantli
greater
control
p
detect
rate
cr
patient
significantli
higher
control
p
ing
posit
signific
differ
overal
multipl
viru
detect
rate
cr
patient
control
p
tabl
rhinoviru
parainfluenza
influenza
rsv
cr
patient
detect
significantli
greater
control
p
rhinoviru
parainfluenza
influenza
p
rsv
tabl
concord
posit
sampl
posit
lavag
scrape
overal
viru
detect
rate
cr
patient
higher
control
subject
p
tabl
like
data
mucos
scrape
rhinoviru
cr
patient
show
significantli
higher
detect
rate
control
subject
p
tabl
known
cr
multifactori
pathogenesi
variou
inflammatori
stimuli
microbi
environment
factor
may
induc
chronic
inflamm
differ
stage
diseas
differ
subgroup
respiratori
virus
caus
florid
sinonas
symptom
cr
patient
may
longlast
effect
sinonas
mucosa
role
respiratori
virus
exacerb
ongo
inflamm
sinu
mucosa
demonstr
number
experiment
studi
howev
studi
evalu
pathogen
impact
communityacquir
respiratori
virus
patient
cr
thu
surveil
studi
viral
respiratori
infect
may
first
step
toward
better
understand
relationship
inflammatori
state
cr
respiratori
viral
infect
present
studi
found
higher
proport
cr
patient
respiratori
virus
nasal
secret
mucosa
compar
noncr
control
specif
multipl
viral
infect
detect
frequent
cr
patient
control
subject
result
suggest
chronic
inflammatori
condit
sinus
nasal
caviti
cr
patient
may
provid
favor
condit
infect
multipl
respiratori
virus
addit
result
also
suggest
communityacquir
respiratori
virus
may
play
anoth
import
role
aggrav
inflamm
cr
similar
bacteria
fungi
studi
rhinoviru
preval
viru
lavag
mucos
scrape
sampl
pcr
analysi
rhinoviru
posit
lavag
sampl
mucos
scrape
sampl
rhinoviru
respiratori
viru
significantli
differ
detect
rate
cr
patient
control
subject
sampl
p
high
preval
rhinoviru
cr
patient
also
confirm
pilot
studi
similar
outcom
report
studi
asthmat
patient
rhinoviru
rna
found
chil
c
detect
rate
cr
patient
significantli
higher
control
p
detect
rate
cr
patient
significantli
higher
control
p
e
four
subtyp
parainfluenza
viru
piv
detect
variou
combin
piv
detect
one
patient
count
one
regardless
mani
subtyp
patient
f
two
subtyp
respiratori
syncyti
viru
rsv
detect
variou
combin
rsv
detect
one
patient
count
one
regardless
mani
subtyp
patient
g
hmpv
human
metapneumoviru
dren
asthma
suggest
rhinoviru
may
import
pathogenesi
asthma
mani
studi
demonstr
high
proport
asthma
patient
respiratori
virus
respiratori
secret
rhinovirus
respiratori
virus
associ
asthma
exacerb
base
current
studi
infect
nasal
caviti
rhinovirus
may
signific
role
promot
symptom
ongo
mucos
inflamm
cr
presenc
respiratori
virus
absenc
symptom
sign
viral
uri
cr
particip
may
explain
sever
way
may
reflect
persist
asymptomat
infect
asymptomat
period
develop
symptomat
infect
presenc
viru
symptomat
infect
howev
nasal
sampl
obtain
particip
show
uri
symptom
preced
week
none
subject
develop
uri
symptom
postop
sampl
collect
hospit
therefor
detect
virus
nasal
sampl
may
due
subclin
persist
respiratori
virus
previou
infect
studi
provid
evid
persist
respiratori
viral
infect
hrv
replic
cell
lower
respiratori
tract
persist
year
previou
studi
group
also
demonstr
persist
infect
parainfluenza
viru
month
patient
olfactori
dysfunct
viru
infect
major
strength
studi
preval
respiratori
viru
assess
use
two
sampl
techniqu
nasal
lavag
mucos
scrape
inferior
turbin
although
respiratori
sampl
detect
respiratori
virus
gener
collect
nasopharyng
swab
nasopharyng
aspir
adult
nasal
lavag
fluid
scrape
inferior
turbin
epitheli
cell
use
detect
respiratori
viru
upper
respiratori
tract
multitechniqu
approach
detect
respiratori
virus
improv
sensit
result
studi
confirm
preval
respiratori
virus
nasal
caviti
cr
patient
howev
consid
mucos
scrape
clinic
signific
specif
method
nasal
lavag
fluid
sinc
turbin
epitheli
cell
may
better
reflect
sinu
mucosa
addit
nasal
lavag
fluid
might
increas
chanc
trap
virus
float
ambient
air
thu
result
higher
falseposit
rate
contain
mix
viral
infect
scrape
sampl
anoth
strength
studi
use
sensit
multiplex
pcr
assay
seeplex
seegen
inc
seoul
south
korea
full
rang
respiratori
virus
studi
also
shown
multiplex
pcr
approach
sensit
detect
respiratori
virus
compar
convent
method
studi
limit
first
differ
baselin
number
case
patient
control
subject
cr
patient
control
subject
addit
control
subject
heterogen
diagnos
compos
patient
chronic
tonsil
n
thyroid
mass
n
howev
great
effort
made
ensur
adequ
select
control
subject
confirm
none
control
subject
experienc
sinus
base
histori
physic
examin
plain
sinu
xray
andor
ct
imag
viral
detect
rate
control
sampl
also
similar
asymptomat
control
subject
anoth
studi
thu
differ
number
subject
case
group
heterogen
control
group
may
confound
find
second
site
sampl
collect
limit
studi
lavag
sampl
collect
nasal
caviti
wherea
mucos
scrape
taken
inferior
turbin
epithelia
thu
sampl
collect
sinu
mucosa
previou
studi
report
respiratori
virus
found
sinu
mucosa
sampl
cr
patient
normal
subject
therefor
may
necessari
determin
whether
respiratori
virus
invad
sinu
mucosa
understand
relationship
cr
pathogenesi
respiratori
virus
third
although
enteroviru
detect
cr
patient
present
studi
potenti
crossreact
rhinoviru
pcr
assay
howev
crossreact
could
ignor
studi
enteroviru
contribut
rel
littl
uri
immunocompet
subject
sensit
seeplex
respiratori
viru
detect
show
compat
revers
transcriptas
pcr
summari
studi
detect
higher
preval
respiratori
viru
infect
cr
patient
control
variou
respiratori
virus
rhinoviru
far
preval
viru
viru
significantli
differ
detect
rate
two
group
result
suggest
may
strong
associ
mucos
inflamm
cr
respiratori
viral
infect
particularli
rhinoviru
infect
studi
investig
etiolog
role
high
detect
rate
respiratori
virus
cr
patient
symptomat
aggrav
ongo
mucos
inflamm
